Novalpina buys majority stake in Laboratoire XO

UK-based private equity firm Novalpina Capital has acquired a majority stake in Laboratoire XO, a French pharmaceutical company focused on the production and distribution of prescription drugs treating chronic diseases.

Relaxation of Covid-19 aid rules may help PE-backed firms – but will it be enough?

The Government's adjustment to aid for businesses is a welcome step for private equity firms, but it may be a false dawn

Bain Capital Ventures, Silversmith among VCs helping risk management solution Venminder to $33m Series C

Third-party risk management solution developer Venminder has scored $33m in its Series C round, which was led by Silversmith Capital Partners.

Google, Andreessen Horowitz back cloud-native networking company Isovalent

Isovalent, a cloud-native networking company, has launched its services to help enterprises connect, observe and secure modern applications with its Cilium product.

AlpInvest, APG private equity co-founder Iain Leigh joins The Riverside Company advisory board

Lower mid-market private equity specialist The Riverside Company has brought in former AlpInvest North America head Iain Leigh in the wake of his retirement from APG Asset Management.

Coherent scores $14m in its Series A round

Coherent, which helps insurers build digital-first services, has scored $14m in its Series A funding round.

PAI acquires Angulas Aguinaga from Portobello

PAI Partners has acquired a majority stake in fish specialist Angulas Aguinaga from Spanish GP Portobello Capital.

New Mountain Capital buys health benefits administrator HealthComp from Alpine Investors

Private equity major New Mountain Capital has bought healthcare benefits administrator HealthComp from Alpine Investors.

Graphite promotes new investment director, hires two

UK mid-cap GP Graphite Capital has promoted Lara Markham to investment director, and hired two extra professionals in its investment team.

Venture capital firms help health data sharing startup Human API to Series C success

Human API, which is helping consumers to connect and share electronic health data with companies, has bagged $20m in its Series C.

GHO, co-investors complete Envision deal

GHO Capital and some of its LPs have secured the majority stake in Envision Pharma previously held by Ardian.

German resilience helps DACH region towards record PE deal value total despite Covid-19 volatility

German resilience is helping the DACH region power towards its highest annual private equity deal value total for a decade despite the bruising impact of the coronavirus pandemic on firms across the globe.

Buyout rankings: who has invested most across Europe since April?

Unquote tallies the top 10 most active GPs across the European buyout space amid the coronavirus turmoil.

Nordic Capital carves-out RegTech from BearingPoint

The German company is expected to generate revenues of close to €100m in 2020

GPs must embrace proactive portfolio management tools now, or be left behind

As the coronavirus crisis continues to rage across the glove, private equity investors are being forced to think more carefully about managing their existing portfolios amid a volatile dealmaking market. AltAssets spoke to Eaton Partners'

Nordic Capital carves out RegTech from BearingPoint

Nordic Capital has acquired a majority stake in German company BearingPoint's regulatory tech subsidiary RegTech.

Preparing for the turnarounds wave

While advisers readied themselves for a wave of distressed opportunities off the back of the coronavirus crisis – and GPs anticipated a shift in LP allocation strategies – the turnarounds surge has failed to materialise.

KKR Invests with NextEra Energy and NextEra Energy Partners in Portfolios of Renewable Energy Assets

NEW YORK--(BUSINESS WIRE)-- Global investment firm KKR today announced the signing of agreements with NextEra Energy Resources, LLC, a subsidiary of NextEra Energy, Inc. (NYSE: NEE), and NextEra Energy Partners, LP (NYSE: NEP) relating to

We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.
We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.